glutathione transporter Glutathione transferases: substrates, inihibitors and pro-drugs in cancer and neurodegenerative diseases Glutathione transporter as a target

The maintenance frequency approach offers middle ground where users completing intensive initial treatment (6-12 months daily) transition to reduced frequency (2-4 times weekly) maintaining copper supplementation at lower intensity and cost while avoiding complete discontinuation allowing some benefit decline

Addressing psoriasis comorbidities with peptides Psoriasis rarely exists in isolation

Peer review Peer review information Nature Immunology thanks Felipe Andrade, Andras Perl, and the other, anonymous, reviewer(s) for their contribution to the peer review of this work

Do not squirt directly onto the powder

What's the difference between cagrilintide and pramlintide